Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
San Gabriel Valley Index
San Gabriel Valley
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Precision Biosciences Inc
(NQ:
DTIL
)
9.655
-0.285 (-2.87%)
Streaming Delayed Price
Updated: 12:49 PM EDT, Aug 27, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Precision Biosciences Inc
< Previous
1
2
3
4
5
6
7
8
9
Next >
Precision BioSciences Announces Grant of Inducement Award Pursuant to Nasdaq Listing Rule 5635(c)(4)
October 26, 2022
From
Precision BioSciences, Inc.
Via
Business Wire
12 Health Care Stocks Moving In Tuesday's After-Market Session
October 18, 2022
Gainers
Via
Benzinga
Precision BioSciences to Present at the European Society of Gene & Cell Therapy (ESGCT) 29th Congress
October 11, 2022
From
Precision BioSciences, Inc.
Via
Business Wire
Precision BioSciences to Participate in Upcoming Jefferies Cell & Genetic Medicine Summit
September 22, 2022
From
Precision BioSciences, Inc.
Via
Business Wire
Why Precision BioSciences Shares Are Surging Today
June 22, 2022
Via
Benzinga
Precision BioSciences to Participate in Upcoming H.C. Wainwright 24th Annual Global Investment Conference
September 07, 2022
From
Precision BioSciences, Inc.
Via
Business Wire
Precision BioSciences Announces Senior Leadership Organizational Changes
September 02, 2022
From
Precision BioSciences, Inc.
Via
Business Wire
Looking Into Precision BioSciences, Inc. - Common Stock's Return On Capital Employed
August 30, 2022
Benzinga Pro data, Precision BioSciences, Inc. - Common Stock (NASDAQ:DTIL) reported Q2 sales of $3.82 million. Earnings fell to a loss of $31.04 million, resulting in a 10.18% decrease from last...
Via
Benzinga
Precision BioSciences: Q2 Earnings Insights
August 08, 2022
Precision BioSciences (NASDAQ:DTIL) reported its Q2 earnings results on Monday, August 8, 2022 at 07:00 AM. Here's what investors need to know about the announcement.
Via
Benzinga
Precision BioSciences Reports Second Quarter 2022 Financial Results and Provides Business Update
August 08, 2022
From
Precision BioSciences, Inc.
Via
Business Wire
Earnings Preview: Precision BioSciences, Inc. - Common Stock
August 05, 2022
Precision BioSciences, Inc. - Common Stock (NASDAQ:DTIL) is set to give its latest quarterly earnings report on Monday, 2022-08-08. Here's what investors need to know before the announcement.
Via
Benzinga
Precision BioSciences to Report Second Quarter 2022 Financial Results on August 8, 2022
August 01, 2022
From
Precision BioSciences, Inc.
Via
Business Wire
Precision BioSciences Announces Grant of Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
July 25, 2022
From
Precision BioSciences, Inc.
Via
Business Wire
Global Pancreatic Cancer Therapeutics & Diagnostics Market Expected To Reach $5.6 Billion By 2027
June 28, 2022
Palm Beach, FL – June 28, 2022 – FinancialNewsMedia.com News Commentary – Pancreatic cancer therapeutics and diagnostics involve medical procedures used to diagnose pancreatic cancer and subsequent...
Via
FinancialNewsMedia
Precision BioSciences Announces Closing of Underwritten Offering of Common Stock
June 27, 2022
From
Precision BioSciences, Inc.
Via
Business Wire
This Healthcare Stock Jumps Around 188%, Here's 83 Biggest Movers From Yesterday
June 28, 2022
Gainers Evofem Biosciences, Inc. (NASDAQ: EVFM) shares jumped 187.7% to close at $1.07 on Monday amid the Supreme Court overturning Roe V Wade.
Via
Benzinga
76 Biggest Movers From Yesterday: Ocean Bio-Chem, Athira Pharma And More
June 23, 2022
Gainers Ocean Bio-Chem, Inc. (NASDAQ: OBCI) shares climbed 117.2% to close at $12.86 on Wednesday after the company announced it will be acquired by OneWater Marine for $13.08 per share in cash.
Via
Benzinga
40 Stocks Moving In Wednesday's Mid-Day Session
June 22, 2022
Gainers Ocean Bio-Chem, Inc. (NASDAQ: OBCI) shares jumped 116.6% to $12.82 after the company announced it will be acquired by OneWater Marine for $13.08 per share in cash.
Via
Benzinga
Exela Technologies (XELA) Stock Soars After Securing $136 Million Contract
June 22, 2022
Exela Technologies (XELA) stock is taking off on Wednesday after gaining a new $136 million customer contract that lasts for three years.
Via
InvestorPlace
Athira Pharma (ATHA) Stock Plunges 65% on Disappointing Drug Trial Results
June 22, 2022
Athira Pharma (ATHA) stock is plummeting on Wednesday following the outcome of a Phase 2 clinical trial of fosgonimeton.
Via
InvestorPlace
Precision BioSciences (DTIL) Stock Treks Higher on Novartis Deal
June 22, 2022
DTIL stock is advancing in early trading today after Precision BioScience announced a partnership with Novartis, a leading drug maker.
Via
InvestorPlace
Futures, Oil Tumble As Attention Turns To Coming Recession, Powell Senate Testimony
June 22, 2022
Tuesday's euphoric market mood has U-turned into sheer despair with most of yesterday's gains gone overnight as attention turns to the coming US recession.
Via
Talk Markets
The Daily Biotech Pulse: Precision BioSciences Inks Gene Editing Pact, Athira Pharma's Alzheimer's Candidate Fails, Enanta Sues Pfizer Over COVID-19 Antiviral
June 22, 2022
Here's a roundup of top developments in the biotech space over the last 24 hours:
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
June 22, 2022
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday
June 22, 2022
Good morning! It's time to start off another busy day of trading with a look at the biggest pre-market stock movers for Wednesday!
Via
InvestorPlace
21 Stocks Moving in Wednesday's Pre-Market Session
June 22, 2022
Gainers Codex DNA, Inc. (NASDAQ: DNAY) rose 64.5% to $3.52 in pre-market trading after declining 10% on Tuesday.
Via
Benzinga
US Stock Futures Down; Powell Testimony In Focus
June 22, 2022
Pre-open movers U.S. stock futures traded lower in early pre-market trade after the Dow Jones gained more than 600 points in the previous session.
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's After-Market Session
June 21, 2022
Gainers
Via
Benzinga
Precision BioSciences Announces $50 Million Offering of Common Stock
June 21, 2022
From
Precision BioSciences, Inc.
Via
Business Wire
Precision BioSciences Announces In Vivo Gene Editing Collaboration with Novartis to Develop Potentially Curative Treatment for Disorders Including Sickle Cell Disease
June 21, 2022
From
Precision BioSciences, Inc.
Via
Business Wire
< Previous
1
2
3
4
5
6
7
8
9
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.